AIGH Capital Management’s PolyPid PYPD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.64M Sell
1,504,741
-88,846
-6% -$410K 0.48% 26
2026
Q1
$6.98M Buy
1,593,587
+250,615
+19% +$1.11M 0.95% 26
2025
Q4
$5.83M Buy
1,342,972
+277,844
+26% +$1.03M 1.41% 21
2025
Q3
$3.55M Sell
1,065,128
-128,980
-11% -$447K 1% 26
2025
Q2
$4.22M Buy
1,194,108
+253,727
+27% +$743K 1.9% 21
2025
Q1
$2.55M Buy
940,381
+112,514
+14% +$335K 1.06% 28
2024
Q4
$2.51M Buy
827,867
+148,199
+22% +$487K 0.78% 25
2024
Q3
$2.37M Buy
679,668
+200,422
+42% +$720K 0.67% 24
2024
Q2
$2.05M Hold
479,246
0.64% 25
2024
Q1
$2.27M Buy
+479,246
New +$2.9M 0.68% 31

Other funds holding PYPD

AIGH Capital Management's PYPD Position: Q2 2026 in Review

AIGH Capital Management reduced its PolyPid (PYPD) stake by 5.6% in Q2 2026, selling an estimated $410K and leaving 1,504,741 shares worth $7.64M. The position accounts for 0.48% of the portfolio, ranked #26.

AIGH Capital Management first reported a position in PYPD in Q1 2024 and has held it in 10 quarters since. 8 funds tracked by Wall St. Rank hold PYPD as of Q2 2026.

  • AIGH Capital Management held 1,504,741 shares of PolyPid worth $7.64M as of Q2 2026.
  • AIGH Capital Management sold 88,846 PolyPid shares in Q2 2026, an estimated $410K.
  • PolyPid made up 0.48% of AIGH Capital Management's portfolio in Q2 2026, its #26 holding.
  • AIGH Capital Management first reported a position in PolyPid in Q1 2024 and has held it in 10 quarters since.
  • 8 funds tracked by Wall St. Rank held PolyPid as of Q2 2026.

Based on AIGH Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.